Pandect Bioventures
Venture capitalWoodside · Seed–Late Stage · 10 people tracked
Investment thesis
Pandect Bioventures focuses on transformational healthcare and life science opportunities at the earliest stage. It leverages an ecosystem of a 40,000 square foot incubator facility, exclusive relationships with research institutions, and experienced academic and industry advisors to source and grow investments. Executives-in-residence and management bring decades of operating experience to portfolio companies. Opportunities are evaluated through a rigorous assessment process, with funding spanning seed, Series A, and later rounds. The firm frequently co-invests alongside other life science investors and forms new companies with academic co-founders drawn from leading research institutions.
Source: firm website, verified Aug 11, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Medical Devices ×5Healthtech ×2AI & Machine Learning ×1Deep Tech ×1Digital Health ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathCircle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Matthew P. Jacobson(Co-founder)David J. Earp(President & CEO)Paul Park(Executive Officer)Scott R. Lokey(Director)Walter Moos(Director)Matthew Jacobson(Director)
Board seatWalter H. Moos· per SEC Form D
Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases.
BiotechDeep TechMedical Devices
Alan Ashworth(Founder)
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Carole H Bellis(Executive Officer)Kevin E Healy(Director)Walter Moos(Director)Jackson M Wesley(Executive Officer, Director)Wesley Jackson(President, Chief Scientific Officer & Member of the Board)Gregory D. Kunst(Chief Executive Officer)
Walden Biosciences is a clinical-stage biotech company developing disease-modifying therapies that selectively target the kidney to treat the underlying drivers of kidney disease.
BiotechMedical Devices
Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.
AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US
Lewis Williams(Co-founder & CEO)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)Franklin M. Berger(Director)
Frequently asked questions
- What stage does Pandect Bioventures invest at?
- Pandect Bioventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Pandect Bioventures focus on?
- Pandect Bioventures focuses on Biotech, Healthtech, Longevity, Medical Devices.
- Where is Pandect Bioventures located?
- Pandect Bioventures is headquartered in Woodside, US.
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.